Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 239 (RNA5SP239)

Target
RNA5SP239
Molecular classification
Other (Pseudogene)
01

Overview

RNA, 5S ribosomal pseudogene 239 (abbreviated as RNA5SP239) is a human **pseudogene** related to the 5S ribosomal RNA gene. Unlike the canonical 5S rRNA genes which encode a structural RNA essential for ribosome function and protein synthesis[5][3], this pseudogene does not encode a functional RNA or protein. Pseudogenes like RNA5SP239 are generally considered non-functional remnants of previously functional genes, generated through gene duplication or retrotransposition events[1][2]. While most pseudogenes have no biological role, emerging evidence suggests some can influence gene expression by acting as molecular decoys for microRNAs, as sources of regulatory RNAs, or through interaction with epigenetic regulators[4][6]. However, there is no direct evidence that RNA5SP239 specifically participates in such mechanisms or is involved as a therapeutic target, biomarker, or in disease contexts. It is not considered a therapeutic target, receptor, enzyme, transporter, or transcription factor. **Note:** - This entry is *not a drug target, enzyme, or receptor*. It is a **pseudogene**, and the gene product is *not known to exert direct biological activity or serve as a therapeutic target*[1][2]. - The naming and classification are correct (as a pseudogene), but **not a target**, so `is_incorrect` should be marked as true for any list of canonical therapeutic targets. - If you are seeking actionable drug targets, this gene is not relevant.

Other names
RN5S239RNA5SP239RNA, 5S ribosomal 239
02

Biological functions

Other (No protein-coding function; may have regulatory noncoding RNA functions)
03

Disease associations

Other (No direct disease role established; pseudogenes as a group can be regulatory and have implications in cancer and other diseases through RNA-mediated regulation[6][4])

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 239 (RNA5SP239).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 239 (RNA5SP239).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call